Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges

Cancer is a top global public health concern. At present, molecular targeted therapy has emerged as one of the main therapies for cancer, with high efficacy and safety. The medical world continues to struggle with the development of efficient, extremely selective, and low-toxicity anticancer medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junxia, Chao, Tengfei, Liu, Yingying, Gong, Chen, Zhang, Yinan, Xiong, Huihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305175/
https://www.ncbi.nlm.nih.gov/pubmed/37376154
http://dx.doi.org/10.3390/pharmaceutics15061706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305175/
https://www.ncbi.nlm.nih.gov/pubmed/37376154
http://dx.doi.org/10.3390/pharmaceutics15061706

Ejemplares similares